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http://dx.doi.org/10.1016/j.stemcr.2017.04.007SUMMARYRecent evidence points to the embryonic emergence of some tissue-resident innate immune cells, such as B-1a lymphocytes, prior to and
independently of hematopoietic stem cells (HSCs). However, whether the full hematopoietic repertoire of embryonic HSCs initially in-
cludes these unique lineages of innate immune cells has been difficult to assess due to lack of clonal assays that identify and assess HSC
precursor (pre-HSC) potential. Here, by combining index sorting of single embryonic hemogenic precursorswith in vitroHSCmaturation
and transplantation assays, we analyze emerging pre-HSCs at the single-cell level, revealing their unique stage-specific properties and
clonal lineage potential. Remarkably, clonal pre-HSCs detected between E9.5 and E11.5 contribute to the complete B cell repertoire,
including B-1a lymphocytes, revealing a previously unappreciated common precursor for all B cell lineages at the pre-HSC stage and a
second embryonic origin for B-1a lymphocytes.INTRODUCTION
During embryonic development, hematopoietic cells arise
from transient endothelial-like precursors known as hemo-
genic endothelium (HE), which are found initially in the
yolk sac vascular plexus and later in various intraem-
bryonic and extraembryonic vessels (Frame et al., 2016;
Gordon-Keylock et al., 2013; Yzaguirre and Speck, 2016).
An expanding number of studies have revealed multiple
overlapping waves of hematopoietic progenitors generated
from HE, which give rise to increasingly diverse hemato-
poietic lineages, including progenitors with erythroid,
myeloid, and lymphoid potential detected prior to and
independently of hematopoietic stem cells (HSCs) (Frame
et al., 2013; Hadland et al., 2004; Kobayashi et al., 2014;
Lin et al., 2014; Yoshimoto, 2015; Yoshimoto et al.,
2012). Our group previously identified B-restricted progen-
itors that arise prior to HSCs with distinct B cell potential
that includes B-1a cells, a lineage of tissue-resident B cells
implicated in innate immune responses and autoimmu-
nity (Yoshimoto et al., 2011). Further, mature B-1a cells
are serially transplantable, suggesting an embryonic origin
for life-long B-1a cells independent of HSCs and conven-
tional (B-2) B cells (Kobayashi et al., 2014). Separate studies
demonstrated that highly purified long-term HSCs fromStem Cell R
This is an open access article under the Cthe adult bone marrow, transplanted to adult recipients,
do not contribute significantly to the B-1a subset of B lym-
phocytes (Ghosn et al., 2012), further supporting the
concept of a separate embryonic origin of the innate B-1a
lineage. However, a recent study in which HSCs were
defined functionally by long-term contribution to multili-
neage hematopoiesis using cellular barcoding techniques
indicated contribution to both B-2 and B-1a cells by clonal
fetal stage HSCs, whereas two separate studies examining
whether highly purified fetal liver HSCs contribute to
B-1a cells following transplantation produced conflicting
results, potentially related to differences in phenotypic
markers used for sorting HSCs from the fetal liver (Ghosn
et al., 2016; Kristiansen et al., 2016). These studies suggest
the possibility of heterogeneity within the fetal HSC pool
with regard to B-1a potential and the need to determine
the existence of a common precursor for HSCs and B-1a
cells during early HSC development.
One of the significant challenges in understanding em-
bryonic HSC development has been the lack of methods
to distinguish clonal precursors of HSCs from temporally
and phenotypically overlapping progenitors lacking HSC
potential, which is necessary to identify the unique proper-
ties and lineage potential of emerging HSCs at the single-
cell level. We previously described the generation of aneports j Vol. 8 j 1563–1572 j June 6, 2017 j ª 2017 The Author(s). 1563
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Index Sorting with AGM-EC Co-
culture Identifies Clonal Fgd5-ZsGr+
CD45+/lo Pre-HSC with B-1a and B-2 Cell
Potential
(A) Methodology for detection of clonal HSC
precursors from E11.5 Fgd5ZsGr/+ embryos
combining index sorting of single AGM-
derived cells and AGM-EC co-culture. Dashed
box indicates sample window used for index
sorting Fgd5-ZsGr+CD45+/lo cells.
(B) Phenotypic analysis by FACS of the
progeny of a single cell following 5 days co-
culture, showing a population of cells co-
expressing HSC markers Fgd5-ZsGr, Sca-1,
and EPCR in cells gated as VE-Cadherin
Gr1F4/80.
(C) Representative peripheral blood engraft-
ment in a recipient mouse transplanted with
the progeny of a single cell with the ‘‘HSC’’
phenotype as shown in (B)
(D) Primary and secondary peripheral blood
engraftment from E11.5 pre-HSC clones
(primary engraftment data at 12–16 weeks
post-transplant, secondary engraftment
at >16 weeks post-transplant, from n = 27
clones pooled from two independent experi-
ments; clonal HSC precursor frequency 27
of 564 total index-sorted cells). Mice with
multilineage engraftment are indicated by
data points in red. Mice lacking detectable
peripheral blood engraftment in one or more
lineages are indicated by data points in
black.
(E) Representative E11.5 pre-HSC clone
generating a colony of progeny with ho-
mogeneous VE-CadherinGr1F4/80Fgd5-
ZsGr+Sca1+EPCR+ ‘‘HSC’’ phenotype, with
limit dilution transplantation of the prog-
eny demonstrating primary (1) and sec-
ondary (2) engraftment. HSC frequency of
the progeny calculated by limiting dilution
analysis based on the fraction of mice with
secondary engraftment (ELDA analysis; Hu
and Smyth, 2009) is estimated at 1 in
4.5 cells (95% CI, 1 in 1.4 to 1 in 14),
and total of 156 HSCs generated (95%
CI, 50 to 486). Mice with multilineage
engraftment at 12 weeks post-transplant
in primary and16 weeks post-transplant
in secondary transplants are indicated by
data points in red.
(F and G) Representative engraftment of
(F) B-1a, B-1b and B-2 cells in the peri-
toneum, and (G) B1, marginal zone (MZ),
and follicular (FO) B cells in the spleen,
12 weeks following transplantation of
the progeny (after AGM-EC co-culture) of
(legend continued on next page)
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endothelial cell (EC) niche that supports HSC development
from hemogenic precursors in vitro (Hadland et al., 2015).
This EC niche is derived from the embryonic aorta-gonad-
mesonephros region (AGM-EC), where the first adult-
engrafting HSCs are detected during development. Specif-
ically, we showed that co-culture with AGM-ECs was
sufficient to support the induction of embryonic HE and
pre-HSCs isolated as early as E9.5 to bona fide HSCs, as
defined by their ability to provide long-term, multilineage
engraftment into adult recipients. To build upon these
studies and begin to identify the unique properties and
lineage potential of clonal HSC precursors, we have
adapted this system to analyze the potential of individual
index-sorted hemogenic precursors to give rise to hemato-
poietic progeny, including functional HSCs following
AGM-EC co-culture. Index sorting allows the correlation
of the functional output of each single-sorted cell to its
precise phenotypic properties collected during fluores-
cence-activated cell sorting (FACS), including the distinct
expression intensity of each cell surface marker included
for staining (Schulte et al., 2015). By this approach, here,
we identify clonal precursors from the murine embryonic
para-aortic splanchnopleura (P-Sp)/AGM region from
E9.5 to E11.5 capable of giving rise tomultilineage-engraft-
ing HSCs, elucidating their unique phenotypic properties
and demonstrating a common capacity to contribute to
all B cell lineages including B-1a cells. Importantly, these
studies provide a platform for further investigation of
HSC precursors at single-cell resolution during their emer-
gence and transition to HSCs, which will provide critical
insight toward the future de novo engineering of HSCs
for therapeutic applications.RESULTS
Index Sorting Resolves Clonal E11.5 Pre-HSCs with
Both B-1a and B-2 Cell Lineage Potential
To facilitate screening for HSC potential following AGM-
EC co-culture, we employed a transgenic mouse expressing
Zs-Green (ZsGr) in the Fgd5 locus, which was reported to
enable identification and purification of adult marrow
HSCs, but also marked endothelial cells (Gazit et al.,
2014). In the embryonic P-Sp/AGM, Fgd5-ZsGr expression
is sensitive for, but not specific to, HSC precursors as it
is expressed in all VE-Cadherin+ cells (Figure S1A), which
includes hemogenic precursors as well as non-hemo-
genic endothelial cells at this stage. Following AGM-ECclonal E11.5 AGM-derived Fgd5-ZsGr+CD45+ pre-HSCs, or adult bo
Similar results, demonstrating both B-1a and B-2 peritoneal engraf
(n = 27).
See Table S1.co-culture of AGM-derived Fgd5-ZsGr+VE-Cadherin+ pre-
cursors cells, persistence of Fgd5-ZsGr expression in the
VE-CadherinF4/80Gr1 hematopoietic fraction distin-
guishes the population of hematopoietic cells with long-
term multilineage primary and secondary engraftment
potential (Figures S1B and S1C), thus making it useful in
screening for generation of engrafting cells following co-
culture of hemogenic precursors with AGM-ECs.
To characterize pre-HSCs from E11.5 AGM at the single-
cell level, we index sorted single CD45+/loZsGr+ cells from
dissected E11.5 Fgd5+/ZsGr AGM to individual wells of a
96-well plate containing an AGM-EC layer, and monitored
for growth of hematopoietic colonies. Clonal frequency of
colony formation ranged from 11% to 15% (n = 2). After
5 days of co-culture, cells from all wells, including those
with and without hematopoietic colonies, were harvested
(Figure 1A). Half of the cells from each well were assessed
for expression of Fgd5-ZsGr and other phenotypic HSC
markers, and half were transplanted to lethally irradiated
adult Ly5.1 (CD45.1) congenic C57Bl6 wild-type mice
along with 5 3 104 Ly5.1 rescue whole bone marrow cells
to determine multilineage engraftment potential. By this
approach, we found most hematopoietic colonies contain-
ing cells with VE-CadherinGr1F4/80Sca1+EPCR+Fgd5-
ZsGr+ phenotype (Figure 1B) were capable of long-
term multilineage engraftment determined by detection
of donor-lineage-positive cells in the peripheral blood
(Figure 1C) of transplanted mice, and by detection of
Fgd5-ZsGr+ donor cells with HSC phenotype (Lineage
c-kit+Sca-1+CD48CD150+) in the bone marrow (Fig-
ure S1D). In contrast, neither harvested hematopoietic col-
onies without detectable VE-CadherinGr1F4/80Sca1+
EPCR+Fgd5-ZsGr+ cells nor cells harvested from wells
without hematopoietic colonies provided detectable
engraftment in transplanted mice (data not shown). In
addition to assessing HSC potential following primary
transplantation, we also examined secondary engraftment
from individual pre-HSC clones. Most clonal E11.5 precur-
sors capable of primary multilineage engraftment also
provided multilineage secondary engraftment; however, a
subset did not, suggesting heterogeneity in the ability of
clonal pre-HSCs to give rise toHSCswith robust serial trans-
plantation capacity (Figure 1D). Among engrafting pre-
HSC clones, we also detected heterogeneity in colony
phenotype (compare Figures 1B and 1E) and the extent
of transplantation capacity. Specifically, we detected a sub-
set of pre-HSCs that manifested extensive self-renewal
behavior, generating large numbers of homogeneousne marrow-derived Fgd5-ZsGr+LinSca1+c-kit+CD150+CD48 HSCs.
tment, were obtained in all clones analyzed from E11.5 pre-HSCs
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phenotypic and functional HSCs with robust primary and
secondary multilineage engraftment (Figure 1E), compara-
ble with the proliferative behavior of fetal liver-stage HSCs,
which eventually contribute to the more quiescent adult
HSC pool (Bowie et al., 2007).
Considering recent studies suggesting potential hetero-
geneity in B-1a potential of fetal liver HSCs, single-cell
analysis of embryonic HSC precursors also presented the
unique opportunity to evaluate clonal contribution to
B-1a B cell potential fromdevelopingHSCs prior to the fetal
liver stage. Thus, we examined whether E11.5 pre-HSCs,
which we have shown contribute clonally to long-term
multilineage hematopoiesis in the peripheral blood and
marrow following AGM-EC maturation and transplanta-
tion, also contribute to tissue-resident B-1a cells in the peri-
toneum. We found that all clonal pre-HSCs analyzed at
E11.5 contributed to the complete B cell repertoire,
including B-1a, B-1b, and B-2 cells in the peritoneum (Fig-
ures 1F and Table S1), and B1, marginal zone, and follicular
(B-2) B cells in the spleen (Figure 1G). To rule out the possi-
bility that co-culture on AGM-EC stroma induced B-1a po-
tential in cells that otherwise lacked this potential, we also
tested clonal adult bone marrow-derived Fgd5-ZsGr+Lin
Sca1+c-kit+CD48CD150+ HSCs cultured on AGM-ECs.
Consistent with previous studies in which purified adult
HSCs were directly transplanted (Ghosn et al., 2012), the
progeny of adult HSCs cultured on AGM-ECs contributed
to multilineage hematopoiesis, including marginal zone,
B-2, and B-1b B cells, but did not significantly contribute
to the B-1a lineage detected in the peritoneum of trans-
planted mice (Figures 1F and 1G). Combined with our pre-
vious studies demonstrating an HSC-independent source
of B-1a cells from early E9 yolk sac and P-Sp HE (Yoshimoto
et al., 2011; Kobayashi et al., 2014), these results confirm
a second origin of innate B-1a cells from clonal E11.5
AGM-derived pre-HSCs that is unique to embryonic
development.
Functionally Distinct E9.5 Pre-HSCs Contain B-1a and
B-2 Cell Lineage Potential
At E9.5, P-Sp cells co-expressing endothelial markers and
CD41, the earliest marker of hematopoietic commitment
expressed prior to CD45, represent a heterogeneous
mixture of hematopoietic progenitors, including a rare
population of pre-HSCs (1–2 per embryo) as determined
by limiting dilution re-aggregation assays (Rybtsov et al.,
2014, 2016). To determine whether we could identify these
early pre-HSCs at the single-cell level, individual cells from
E9.5 Fgd5+/ZsGr embryo P-Sp were index sorted based on
CD41 and Zs-Green expression to AGM-ECs in 96-well
plates andmonitored for growth of hematopoietic colonies
(Figure 2A). Clonal frequency of colony formation ranged
from 8% to 27% (18% ± 8%, n = 4). Fgd5-ZsGr+CD41lo1566 Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017cells giving rise to colonies with phenotypic VE-
CadherinGr1F4/80Sca1+EPCR+Fgd5-ZsGr+ cells and
long-term multilineage engraftment were identified, con-
firming a clonal origin for HSC precursors from this earlier
population (Figures 2B and 2C). Compared with pre-HSC
clones identified at E11.5, clonal Fgd5-ZsGr+CD41lo pre-
HSCs detected at E9.5 were rare (less than 1 per embryo
equivalent), contributed less robustly to multilineage
hematopoiesis in secondary transplantation assays (Fig-
ure 2D), and did not generate any homogeneous (exten-
sively self-renewing) HSC colonies that were observed
from E11.5 pre-HSC clones, suggesting distinct properties
of pre-HSC clones arising during this early stage of develop-
ment compared with later pre-HSCs detected at E11.5. We
also examined whether E9.5 pre-HSCs contribute to B-1a
cells. Like pre-HSCs at E11.5, clonal pre-HSCs analyzed
from E9.5 contributed to all B cell subsets examined,
including B-1a, B-1b, and B-2 cells in the peritoneum (Fig-
ures 2E and Table S1), and B1, marginal zone, and follicular
(B-2) B cells in the spleen (Figure 2F). Interestingly, the rela-
tive contribution of pre-HSCs is significantly skewed to-
ward B-1a cells from E9.5 clones and toward B-2 cells
from E11.5 clones (Table S1), providing further evidence
for evolution of distinct, stage-dependent properties of
pre-HSCs between E9.5 and E11.5.
Clonal Pre-HSC Are Distinguished by Unique
Expression of EPCR and Dll4
If pre-HSCs constitute a distinct population among a larger
population of hemogenic precursors lacking HSC potential,
we hypothesized they may be distinguished by the expres-
sion of unique surface markers. Index sorting facilitates the
determination of phenotypic characteristics of different he-
mogenic populations either with or without HSC potential,
by tracking the phenotypic parameters of each individual
cell as it correlates to itshematopoietic potential andengraft-
ment potential following induction on AGM-EC stroma.
Thus, we screened for additional surface markers that could
further enrich for pre-HSCs. At E11.5, we determined that
the subset of Fgd5-ZsGr+CD45+/lo cells expressing high levels
of EPCR, a marker previously shown to be expressed in fetal
andadult long-termHSCsaswell as embryonicpre-HSCsand
multipotent progenitors (Balazs et al., 2006; Inlay et al.,
2014; Iwasaki etal., 2010;Zhouetal., 2016),was significantly
enriched inHSCpotential, identifying a distinct phenotypic
population with HSC potential at approximately 1 in 2 to 1
in 3 cells sorted (Figures 3A and S2A). Clonal pre-HSCs be-
tween E9.5 and E10.5 also express EPCR, although they
remain significantly outnumbered byhemogenic precursors
without HSC potential that are also detected in the Fgd5-
ZsGr+CD41loEPCR+ population at these earlier stages; how-
ever, expression of theNotch ligandDll4, amarker of arterial
endothelium, distinguishes pre-HSCs at these stages since
Figure 2. Clonal Fgd5-ZsGr+CD41lo E9.5
Pre-HSC Have B-1a and B-2 Cell Potential
(A) Methodology for detection of clonal
HSC precursors from E9.5 Fgd5ZsGr/+ embryos
combining index sorting of single P-Sp-
derived cells and AGM-EC co-culture. Dashed
box indicates sample window used for index
sorting Fgd5-ZsGr+CD41lo cells.
(B) Phenotypic analysis by FACS of progeny
of a single cell following 7 day co-culture,
showing a population of cells co-expressing
HSC markers Fgd5-ZsGr, Sca-1, and EPCR in
cells gated as VE-CadherinGr1F4/80.
(C) Representative peripheral blood engraft-
ment in a mouse transplanted with progeny
of a single cell with ‘‘HSC’’ phenotype as
shown in (B).
(D) Primary and secondary peripheral blood
engraftment from E9.5 pre-HSC clones (pri-
mary engraftment data from n = 6 clones
at 12–16 weeks post-transplant, secondary
engraftment data from n = 5 clones
at >16 weeks post-transplant, pooled from
four independent experiments; clonal
HSC precursor frequency 6 of 653 total
index sorted cells). Mice with multilineage
engraftment are indicated by data points
in red. Mice lacking detectable peripheral
blood engraftment in one or more lineages
are indicated by data points in black.
(E and F) Representative engraftment of (E) B-1a, B-1b, and B-2 cells in the peritoneum, and (F) B1, marginal zone (MZ), and follicular (FO)
B cells in the spleen, 12 weeks following transplantation of the progeny (after AGM-EC co-culture) of clonal E9.5 P-Sp-derived Fgd5-
ZsGr+CD41lo pre-HSCs. Similar results, demonstrating both B-1a and B-2 peritoneal engraftment, were obtained in all clones analyzed from
E9.5 pre-HSCs (n = 6).
See Table S1.most EPCR+ precursors lacking HSC potential express lower
levels of Dll4 (Figures 3B, S2B, and S2C). We confirmed
that Dll4 expression also enriched for HSC potential at the
population level in both VE-Cadherin+CD41CD45 HE as
well as VE-Cadherin+CD41+/CD45+ hematopoietic popula-
tions from E9.5 P-Sp, by sorting these populations based
on Dll4 expression followed by AGM-EC co-culture and
transplantation into adult mice (Figure 3C). These results
demonstrate the ability to resolve distinct phenotypic popu-
lations of hemogenic precursors capable of generating
HSCs from those that cannot, which favors the existence
of unique populations of precursors at this stage with and
without HSC potential, rather than simply reflecting ineffi-
ciencies of the co-culture assay.DISCUSSION
To establish methods for the study of the functional and
molecular properties of HSC precursors at the single-celllevel, we have adapted our recently described 2D co-culture
system, in which an engineered AGM-derived EC substrate
provides the necessary in vitro niche for induction of func-
tional HSCs from hemogenic precursors (Hadland et al.,
2015), for clonal studies of index-sorted hemogenic precur-
sors from embryonic development. By this approach, we
have demonstrated that functionally defined, clonal pre-
HSCs are phenotypically distinguishable from progenitors
lacking HSC potential in the E9.5 to E11.5 embryo. Inter-
estingly, we identified Dll4, a Notch ligand expressed on
arterial endothelium, as a phenotypic marker of HSC pre-
cursor potential. Considering recent studies suggesting
that the level of Notch signaling activation must be atten-
uated during the HE to HSC transition, it is interesting to
speculate that co-expression of Dll4 with Notch1 on the
surface of an HSC precursor could serve to limit Notch1
receptor activation by cis-inhibition, a well-established
mechanism regulating Notch signaling in other develop-
ment systems (del A´lamo et al., 2011; Gama-Norton
et al., 2015; Lizama et al., 2015). This could constitute aStem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017 1567
Figure 3. Pre-HSCs Express Distinct Levels of EPCR and Delta-like-4
(A) Expression of EPCR in index-sorted E11.5 AGM-derived Fgd5-ZsGr+CD45+/lo single cells, identifying precursors with HSC potential (pre-
HSC clone), hematopoietic colony formation without HSC potential (non-HSC hemogenic clone), or no hematopoietic colony formation
(non-hemogenic clone) based on functional potential following AGM-EC co-culture. Dashed box contains EPCRhigh-expressing cells highly
enriched for pre-HSC clones.
(B) Expression of EPCR and Delta-like-4 (Dll4) in index-sorted E9.5 (left panel) and E10.5 (right panel) P-Sp/AGM-derived Fgd5-
ZsGr+CD41lo single cells (see also Figure S2 for additional index-sorting parameters).
(C) Engraftment of hematopoietic cells generated following co-culture on AGM-ECs from E9.5 P-Sp hemogenic endothelium (HE, VE-
Cadherin+CD41CD45) and hematopoietic progenitor cells (HPC, VE-Cadherin+CD41+ and/or CD45+) sorted based on expression of Dll4.
Mice with multilineage engraftment at >16 weeks post-transplant are indicated by red data points. Mice lacking detectable peripheral
blood engraftment in one or more lineages are indicated by data points in black.cell-autonomous mechanism to modulate the ability of
pre-HSCs to receive Notch signals induced by trans activa-
tion via Notch ligands known to be expressed on adjacent
endothelial cell stroma (Hadland et al., 2015), which may
be essential for HSC fate, as studies including our own
have demonstrated that fate determination in many devel-
opmental contexts is dependent on precise Notch signal
strength (Dallas et al., 2005; Delaney et al., 2005). Addi-
tional studies will be necessary to determine the functional
significance ofDll4 expression onHSCprecursors in this re-
gard, studies that may provide insight into requirements
for generation of functional HSC from pluripotent stem
cell-derived hemogenic precursors.
Our current study also enabled the assessment of clonal
contribution to in vivo multilineage hematopoiesis from
single cells at the earliest stages of HSC precursor forma-
tion, which has allowed us to identify the earliest common
precursor of B-1a and B-2 cell potential in a clonal precursor
to HSCs as early as E9.5. Recent reports have strengthened
the concept that adult HSCs do not contribute significantly
to the innate B-1a cell compartment, but suggest heteroge-1568 Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017neity in the fetal HSC compartment with regard to B-1a cell
potential (Beaudin et al., 2016; Ghosn et al., 2012, 2016;
Kristiansen et al., 2016; Sawai et al., 2016). Previous studies
by members of our group identified an embryonic HSC-in-
dependent B cell progenitor with B-1 but not B-2 cell po-
tential (Kobayashi et al., 2014; Yoshimoto, 2015; Yoshi-
moto et al., 2011). Our ability to detect significant B-1a
and B-2 cell contribution from all clonal pre-HSC tested
at E9.5 and E11.5 in this study suggests a second wave of
B-1a progenitors developing from a common precursor to
embryonic HSCs.
A recently published study using an irreversible lineage
reporter mouse model identified two distinct populations
of fetal liver HSCs (Beaudin et al., 2016). Although both
types provide long-term multilineage engraftment in
transplantation assays, only one of these fetal HSC popu-
lations contributes to the pool of long-term HSCs in
the adult bone marrow in situ, whereas the other ‘‘devel-
opmentally restricted’’ HSC is primed to contribute
to innate immune cells, including the B-1a lineage.
Our clonal analysis of emerging pre-HSCs suggests
Figure 4. Proposed Model for Multiple Waves of Definitive Hematopoiesis Contributing to B-1a B Cells
Multiple overlapping waves of definitive hematopoiesis emerge within embryonic vessels between E9 and E11.5, giving rise initially to
multilineage progenitors producing erythroid, myeloid, and innate-immune lymphoid progeny independently of HSC (Bo¨iers et al., 2013;
Godin et al., 1993; Inlay et al., 2014; Kobayashi et al., 2014; Yoshimoto et al., 2011; Yoshimoto et al., 2012), followed by emergence of the
earliest clonal pre-HSCs giving rise to ‘‘developmentally restricted’’ HSCs with innate-immune biased lymphoid potential (Beaudin et al.,
2016), and late pre-HSC clones giving rise to a pool of extensively self-renewing fetal liver HSCs that initially have limited B-1a B cell
potential, which is lost as they establish the life-long HSC pool of the adult bone marrow (Ghosn et al., 2012).developmental asynchrony, with E9.5 pre-HSCs gener-
ating a relatively greater proportion of B-1a cells in trans-
plantation assays and unique pre-HSC clones emerging
only later at E11.5 with extensive expansion in vitro of
HSCs with robust primary and secondary engraftment,
consistent with the self-renewing behavior of expanding
fetal liver HSCs that populate the adult marrow (Bowie
et al., 2007). These results suggest that pre-HSCs, arising
asynchronously between E9.5 and E11.5, generate HSCs
with different functional properties and relative B-1a
cell contribution that may account for the distinct popu-
lations of fetal liver HSCs described by Beaudin et al.
(2016).
Altogether, combining the results of these recent studies
with our clonal analysis of pre-HSC lineage potential pre-
sented here, we propose a refined model of developmental
hematopoiesis that incorporates multiple, overlapping
waves of definitive hematopoiesis, progressing through a
multilineage progenitor stage generating innate immune
cells including B-1a but lacking B-2 potential, early pre-
HSCs giving rise to ‘‘developmentally restricted’’ HSCs
that are biased toward generation of innate immune cells
including B-1a but also generate initial B-2 cells, and late
pre-HSCs with limited B-1a potential that is lost as these
cells mature, self-renew, and contribute to the rapidly ex-
panding pool of long-term fetal liver HSCs that eventuallycolonize the adult marrow (Figure 4). Consistent with a
recently reported genetic study proposing distinct, differ-
entially regulated waves of B-1a and B-2 cell development,
this model accounts for three distinct sources of B-1a and
two sources of B-2 cell potential (Montecino-Rodriguez
et al., 2016). Future studies using our approach to define
HSC potential at the clonal level will be required to deter-
mine whether these distinct waves of definitive hemato-
poiesis emerge from separate populations of HE or rather
diverge following emergence of a common pool of CD41+
hematopoietic precursors. Altogether, our studies provide
insight into the developmental origin of HSC heterogene-
ity, with critical implications for engineering HSCs from
pluripotent stem cells and for understanding the ontogeny
of innate immunity.EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL6/J7 (Ly5.2/CD45.2) and congenic C57BL/6.SJL-
Ly5.1-Pep3b (Ly5.1/CD45.1) mice were bred at the Fred Hutchin-
son Cancer Research Center. Transgenic Fgd5Zs-Green/+ mice in
C57BL6/J7 background were generated as previously described
(Gazit et al., 2014). C57BL6/J7 Ly5.2 or Fgd5Zs-Green/+ male and
wild-type C57BL6/J7 Ly5.2 female mice were used for timed
matings.Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017 1569
Embryo Dissections and Cell Sorting
Embryo P-Sp/AGM tissues were harvested as previously described
(Hadland et al., 2015). Embryo agewas precisely timedby counting
somite pairs (sp): E9.5 (21–29sp), E10.5 (35–39sp), and E11.5 (40–
47sp). Dissected AGM/P-Sp tissues were treated with 0.25% colla-
genase (STEMCELL Technologies) for 25 min at 37C, pipetted to
a single-cell suspension, and washed with PBS containing 10%
fetal bovine serum (FBS). Cells were incubated with anti-mouse
CD16/CD32 (FcgRII block) and stained with monoclonal anti-
bodies as indicated. A detailed list of all antibodies used is shown
in Table S2. DAPI staining was used to gate out dead cells. All re-
agents for cell staining were diluted in PBS with 10% FBS, and
staining was carried out on ice or at 4C. Cells were sorted on a
BD FACSAria II equipped with BD FACSDiva Software with in-
dex-sorting capability. For index-sorted single cells, sorting was
performed in single-cellmodewithmaximumpuritymask settings
to minimize contaminating cells.
Endothelial Cell Co-culture Assays
AGM-ECswerederived fromECs sorted fromE10.5 to E11.5AGMre-
gions, infected with lentivirus containing MyrAKT construct, and
culturedaspreviouslydescribed (Hadlandetal., 2015). Forco-culture
experiments, AGM-ECs at passage 15 or less were plated at a density
of13104 cells perwell togelatin-treated96-well tissue cultureplates
for single-cell assays, or 4 3 104 cells per 24-well for bulk cultures,
24 hr prior to initiation of co-culture. Single P-Sp/AGM-derived cells
were individually index sorted to eachwell of 96-well plates contain-
ing AGM-ECs in serum-free media consisting of X-vivo 20 (Lonza)
with recombinant cytokines (Peprotech): stem cell factor and FLT3
ligand each at 100 ng/mL, and interleukin-3, and thrombopoietin
each at 20 ng/mL. Cells from E9.5 embryos were cultured for
7 days, and cells from E10.5 to 11.5 embryos were cultured for 5–
6 days, based on prior studies that determined the time required to
detect engrafting populations following culture from precursors at
different stages (Hadland et al., 2015). Following co-culture, each
well was visualized for hematopoietic colony formation, and wells
with more than one colony were excluded from analysis. In some
experiments, wells without visible hematopoietic colonies were
also harvested for phenotypic and transplantation analysis to assay
for HSC generation in the absence of colony formation.
Cell Surface Analysis
Following co-culture, 50% volume of each 96-well containing a
visible colony was harvested by vigorous pipetting from the EC
layer and transferred to new 96-well plates for FACS. Cells were
spun and re-suspended in PBS with 2% FBS, pre-incubated with
anti-mouse CD16/CD32 (FcgRII block) and then stained with
various combinations of monoclonal antibodies as indicated.
AGM-ECs were excluded from analysis of co-cultured cells by
gating based on expression of VE-Cadherin, and myeloid cells
were gated by expression of Gr-1 and F4/80. DAPI was used to
exclude dead cells. Flow cytometry was performed on a Becton
Dickinson Canto 2 and data analyzed using FlowJo Software.
Transplantation Assays
Freshly sorted Ly5.2/CD45.2 AGM cells or cultured cells harvested
by pipetting off the wells were washed with PBS with 2% FBS and1570 Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017re-suspended in 100 mL of PBS/2% FBS permouse transplanted. For
clonal assays, the remaining 50% volume following FACS analysis
of each 96-well plate containing a visible colony was harvested
individually for transplantation. For most experiments, only col-
onies with detectable VE-CadherinGr1F4/80Sca1+EPCR+Fgd5-
ZsGr+ cells by FACS were transplanted based on initial studies
demonstrating that colonies lacking this phenotype did not pro-
vide detectable hematopoietic engraftment in transplanted mice.
Freshly harvested Ly5.1/CD45.1 bone marrow cells were added at
53 104 cells in 100 mL of PBS/FBS permouse to providehematopoi-
etic rescue. Cells were co-injected into lethally irradiated (1,000
cGy using a cesium source) Ly5.1/CD45.1 adult recipients via the
tail vein. For secondary transplants, 2 3 106 whole bone marrow
cells harvested from primary recipients 12–16 weeks following
primary transplantation were transplanted to lethally irradiated
Ly5.1/CD45.1 recipients via the tail vein. FACS analysis of periph-
eral blood obtained by retro-orbital bleeds was performed at 2, 6,
and 12–16 weeks following transplantation, and from cells ob-
tained from harvested bone marrow, spleen, and thymic tissues,
and peritoneal fluid at the time of secondary transplant, at 12–
16weeks following primary transplant. FACS analysis of peripheral
bloodwas performed at 16 weeks following secondary transplanta-
tion. Peritoneal cells were harvested by injecting 6 mL of PBS with
a 21G needle and syringe through the peritoneal membrane into
the peritoneal space and collecting back injected fluid. Lineage-
specific staining from donor (CD45.2) and recipient/rescue
(CD45.1) cells for peripheral blood, bone marrow, spleen, thymus,
and peritoneal-derived cells was performed as previously described
(Hadland et al., 2015; Kobayashi et al., 2014), using antibodies
listed in Table S2. Multilineage engraftment was defined as >5%
donor (CD45.2) contribution to the peripheral blood with detect-
able contribution of donor myeloid (Gr-1 and/or F4/80), B cells
(CD19), and T cells (CD3).Statistics
For statistical analysis, two-tailed, unpaired Student’s t test was
used to calculate p values. A p value less than 0.05 was considered
significant. ELDA software (Hu and Smyth, 2009) (http://bioinf.
wehi.edu.au/software/elda/) was used for limit dilution transplan-
tation analysis, calculated using the fraction of mice engrafted at
each dilution of starting cells expressed per embryo equivalent,
where engraftment was defined as >5% donor (CD45.2) contribu-
tion to the peripheral blood with each of donor myeloid (Gr-1
and/or F4/80), B cell (CD19) and Tcell (CD3) engraftment detected
in secondarily transplanted mice at 16 weeks post-transplant.Animal Study Approval
All animal studies were conducted in accordance with the NIH
guidelines for humane treatment of animals and were approved
by the Institutional Animal Care and Use Committee at the Fred
Hutchinson Cancer Research Center.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and two tables and
can be found with this article online at http://dx.doi.org/10.1016/
j.stemcr.2017.04.007.
AUTHOR CONTRIBUTIONS
B.K.H., B.V., I.D.B., S.R, J.M.B., M.G.P., M.C.Y., and M.Y. designed
experiments. B.K.H., B.V., and M.Y. conducted experiments.
P.K.M. and D.J.R. provided Fgd5Zs-Green/+ mice. B.K.H. and B.V.
wrote the manuscript and I.B., M.C.Y., P.K.M., D.J.R., andM.Y. edi-
ted the manuscript.ACKNOWLEDGMENTS
We thank Cynthia McKay and David A. Flowers for their superb
technical assistance. This work was supported by the NIH: NHLBI
UO1 HL100395, Ancillary HL100395-07 Sub-award 10560, Ancil-
lary HL099997, NIAID R56 AI110831, and NIAID R01 AI121197.
Brandon Hadland is supported by the Alex’s Lemonade Stand
Foundation and Hyundai Hope on Wheels Foundation
Received: January 18, 2017
Revised: April 5, 2017
Accepted: April 6, 2017
Published: May 4, 2017REFERENCES
Balazs, A.B., Fabian, A.J., Esmon, C.T., and Mulligan, R.C. (2006).
Endothelial protein C receptor (CD201) explicitly identifies he-
matopoietic stem cells in murine bone marrow. Blood 107,
2317–2321.
Beaudin, A.E., Boyer, S.W., Perez-Cunningham, J., Hernandez,
G.E., Derderian, S.C., Jujjavarapu, C., Aaserude, E., MacKenzie,
T., and Forsberg, E.C. (2016). A transient developmental hemato-
poietic stem cell gives rise to innate-like B and T cells. Cell Stem
Cell 19, 768–783.
Bowie, M.B., Kent, D.G., Dykstra, B., McKnight, K.D., McCaffrey,
L., Hoodless, P.A., and Eaves, C.J. (2007). Identification of a new
intrinsically timed developmental checkpoint that reprograms
key hematopoietic stem cell properties. Proc. Natl. Acad. Sci. USA
104, 5878–5882.
Bo¨iers, C., Carrelha, J., Lutteropp, M., Luc, S., Green, J.C., Azzoni,
E., Woll, P.S., Mead, A.J., Hultquist, A., Swiers, G., et al. (2013).
Lymphomyeloid contribution of an immune-restricted progenitor
emerging prior to definitive hematopoietic stem cells. Cell Stem
Cell 13, 535–548.
Dallas, M.H., Varnum-Finney, B., Delaney, C., Kato, K., and Bern-
stein, I.D. (2005). Density of the Notch ligand Delta1 determines
generation of B and T cell precursors from hematopoietic stem
cells. J. Exp. Med. 201, 1361–1366.
del A´lamo,D., Rouault, H., and Schweisguth, F. (2011).Mechanism
and significance of cis-inhibition in Notch signalling. Curr. Biol.
21, R40–R47.
Delaney, C., Varnum-Finney, B., Aoyama, K., Brashem-Stein, C.,
and Bernstein, I.D. (2005). Dose-dependent effects of the Notch
ligand Delta1 on ex vivo differentiation and in vivo marrow repo-
pulating ability of cord blood cells. Blood 106, 2693–2699.
Frame, J.M., McGrath, K.E., and Palis, J. (2013). Erythro-myeloid
progenitors: ‘‘definitive’’ hematopoiesis in the conceptus prior tothe emergence of hematopoietic stem cells. Blood Cells Mol. Dis.
51, 220–225.
Frame, J.M., Fegan, K.H., Conway, S.J., McGrath, K.E., and Palis, J.
(2016). Definitive hematopoiesis in the yolk sac emerges from
Wnt-responsive hemogenic endothelium independently of circu-
lation and arterial identity. Stem Cells 34, 431–444.
Gama-Norton, L., Ferrando, E., Ruiz-Herguido, C., Liu, Z., Guiu, J.,
Islam, A.B., Lee, S.U., Yan, M., Guidos, C.J., Lo´pez-Bigas, N., et al.
(2015). Notch signal strength controls cell fate in the haemogenic
endothelium. Nat. Commun. 6, 8510.
Gazit, R.,Mandal, P.K., Ebina,W., Ben-Zvi, A., Nombela-Arrieta, C.,
Silberstein, L.E., and Rossi, D.J. (2014). Fgd5 identifies hematopoi-
etic stem cells in themurine bonemarrow. J. Exp. Med. 211, 1315–
1331.
Ghosn, E.E., Yamamoto, R., Hamanaka, S., Yang, Y., Herzenberg,
L.A., and Nakauchi, H. (2012). Distinct B-cell lineage commitment
distinguishes adult bone marrow hematopoietic stem cells. Proc.
Natl. Acad. Sci. USA 109, 5394–5398.
Ghosn, E.E., Waters, J., Phillips, M., Yamamoto, R., Long, B.R.,
Yang, Y., Gerstein, R., Stoddart, C.A., Nakauchi, H., and Herzen-
berg, L.A. (2016). Fetal hematopoietic stem cell transplantation
fails to fully regenerate the B-lymphocyte compartment. Stem
Cell Rep. 6, 137–149.
Godin, I.E., Garcia-Porrero, J.A., Coutinho, A., Dieterlen-Lie`vre, F.,
and Marcos, M.A. (1993). Para-aortic splanchnopleura from early
mouse embryos contains B1a cell progenitors. Nature 364, 67–70.
Gordon-Keylock, S., Sobiesiak,M., Rybtsov, S.,Moore, K., andMed-
vinsky, A. (2013). Mouse extraembryonic arterial vessels harbor
precursors capable of maturing into definitive HSCs. Blood 122,
2338–2345.
Hadland, B.K., Huppert, S.S., Kanungo, J., Xue, Y., Jiang, R., Grid-
ley, T., Conlon, R.A., Cheng, A.M., Kopan, R., and Longmore,
G.D. (2004). A requirement for Notch1 distinguishes 2 phases of
definitive hematopoiesis during development. Blood 104, 3097–
3105.
Hadland, B.K., Varnum-Finney, B., Poulos, M.G., Moon, R.T., But-
ler, J.M., Rafii, S., and Bernstein, I.D. (2015). Endothelium and
NOTCH specify and amplify aorta-gonad-mesonephros-derived
hematopoietic stem cells. J. Clin. Invest. 125, 2032–2045.
Hu, Y., and Smyth, G.K. (2009). ELDA: extreme limiting dilution
analysis for comparing depleted and enriched populations in
stem cell and other assays. J. Immunol. Methods 347, 70–78.
Inlay, M.A., Serwold, T., Mosley, A., Fathman, J.W., Dimov, I.K.,
Seita, J., and Weissman, I.L. (2014). Identification of multipotent
progenitors that emerge prior to hematopoietic stem cells in em-
bryonic development. Stem Cell Rep. 2, 457–472.
Iwasaki, H., Arai, F., Kubota, Y., Dahl,M., and Suda, T. (2010). Endo-
thelial protein C receptor-expressing hematopoietic stem cells
reside in the perisinusoidal niche in fetal liver. Blood 116, 544–553.
Kobayashi, M., Shelley, W.C., Seo, W., Vemula, S., Lin, Y., Liu, Y.,
Kapur, R., Taniuchi, I., and Yoshimoto, M. (2014). Functional B-1
progenitor cells are present in the hematopoietic stem cell-defi-
cient embryo and depend on Cbfb for their development. Proc.
Natl. Acad. Sci. USA 111, 12151–12156.Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017 1571
Kristiansen, T.A., Jaensson Gyllenba¨ck, E., Zriwil, A., Bjo¨rklund, T.,
Daniel, J.A., Sitnicka, E., Soneji, S., Bryder, D., and Yuan, J. (2016).
Cellular barcoding links B-1a B cell potential to a fetal hematopoi-
etic stem cell state at the single-cell level. Immunity 45, 346–357.
Lin, Y., Yoder, M.C., and Yoshimoto,M. (2014). Lymphoid progen-
itor emergence in the murine embryo and yolk sac precedes stem
cell detection. Stem Cells Dev. 23, 1168–1177.
Lizama, C.O., Hawkins, J.S., Schmitt, C.E., Bos, F.L., Zape, J.P., Cau-
tivo, K.M., Borges Pinto, H., Rhyner, A.M., Yu, H., Donohoe, M.E.,
et al. (2015). Repression of arterial genes in hemogenic endothe-
lium is sufficient for haematopoietic fate acquisition. Nat. Com-
mun. 6, 7739.
Montecino-Rodriguez, E., Fice, M., Casero, D., Berent-Maoz, B.,
Barber, C.L., and Dorshkind, K. (2016). Distinct genetic networks
orchestrate the emergence of specific waves of fetal and adult B-1
and B-2 development. Immunity 45, 527–539.
Rybtsov, S., Batsivari, A., Bilotkach, K., Paruzina, D., Senserrich, J.,
Nerushev, O., and Medvinsky, A. (2014). Tracing the origin of
the HSC hierarchy reveals an SCF-dependent, IL-3-independent
CD43(-) embryonic precursor. Stem Cell Rep. 3, 489–501.
Rybtsov, S., Ivanovs, A., Zhao, S., and Medvinsky, A. (2016). Con-
cealed expansion of immature precursors underpins acute burst
of adult HSC activity in foetal liver. Development 143, 1284–1289.
Sawai, C.M., Babovic, S., Upadhaya, S., Knapp, D.J., Lavin, Y., Lau,
C.M., Goloborodko, A., Feng, J., Fujisaki, J., Ding, L., et al. (2016).1572 Stem Cell Reports j Vol. 8 j 1563–1572 j June 6, 2017Hematopoietic stem cells are the major source of multilineage he-
matopoiesis in adult animals. Immunity 45, 597–609.
Schulte, R., Wilson, N.K., Prick, J.C., Cossetti, C., Maj, M.K., Gott-
gens, B., and Kent, D.G. (2015). Index sorting resolves heteroge-
neousmurine hematopoietic stem cell populations. Exp. Hematol.
43, 803–811.
Yoshimoto, M. (2015). The first wave of B lymphopoiesis develops
independently of stem cells in themurine embryo. Ann.N. YAcad.
Sci. 1362, 16–22.
Yoshimoto, M., Montecino-Rodriguez, E., Ferkowicz, M.J., Poray-
ette, P., Shelley, W.C., Conway, S.J., Dorshkind, K., and Yoder,
M.C. (2011). Embryonic day 9 yolk sac and intra-embryonic hemo-
genic endothelium independently generate a B-1 and marginal
zone progenitor lacking B-2 potential. Proc. Natl. Acad. Sci. USA
108, 1468–1473.
Yoshimoto,M., Porayette, P., Glosson, N.L., Conway, S.J., Carlesso,
N., Cardoso, A.A., Kaplan, M.H., and Yoder, M.C. (2012). Autono-
mous murine T-cell progenitor production in the extra-embryonic
yolk sac before HSC emergence. Blood 119, 5706–5714.
Yzaguirre, A.D., and Speck,N.A. (2016). Insights into blood cell for-
mation from hemogenic endothelium in lesser-known anatomic
sites. Dev. Dyn. 245, 1011–1028.
Zhou, F., Li, X., Wang, W., Zhu, P., Zhou, J., He, W., Ding, M.,
Xiong, F., Zheng, X., Li, Z., et al. (2016). Tracing haematopoietic
stem cell formation at single-cell resolution. Nature 533, 487–492.
